Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
25,125
archived clinical trials in
Diabetes

Compare Two Dosing Algorithms in Insulin-Naive Patients With Type 2 Diabetes Mellitus
A Phase 3, Open-Label, Parallel-Group Study to Compare Two Dosing Algorithms for Preprandial Human Insulin Inhalation Powder (HIIP) in Insulin-Naive Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  3/7/2018
Clinical Research Facility
mi
from
Austin, TX
Compare Two Dosing Algorithms in Insulin-Naive Patients With Type 2 Diabetes Mellitus
A Phase 3, Open-Label, Parallel-Group Study to Compare Two Dosing Algorithms for Preprandial Human Insulin Inhalation Powder (HIIP) in Insulin-Naive Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 3/7/2018
Clinical Research Facility
mi
from
Austin, TX
Click here to add this to my saved trials
Compare Two Dosing Algorithms in Insulin-Naive Patients With Type 2 Diabetes Mellitus
A Phase 3, Open-Label, Parallel-Group Study to Compare Two Dosing Algorithms for Preprandial Human Insulin Inhalation Powder (HIIP) in Insulin-Naive Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  3/7/2018
Clinical Research Facility
mi
from
San Antonio, TX
Compare Two Dosing Algorithms in Insulin-Naive Patients With Type 2 Diabetes Mellitus
A Phase 3, Open-Label, Parallel-Group Study to Compare Two Dosing Algorithms for Preprandial Human Insulin Inhalation Powder (HIIP) in Insulin-Naive Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 3/7/2018
Clinical Research Facility
mi
from
San Antonio, TX
Click here to add this to my saved trials
Compare Two Dosing Algorithms in Insulin-Naive Patients With Type 2 Diabetes Mellitus
A Phase 3, Open-Label, Parallel-Group Study to Compare Two Dosing Algorithms for Preprandial Human Insulin Inhalation Powder (HIIP) in Insulin-Naive Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  3/7/2018
Clinical Research Facility
mi
from
Salt Lake City, UT
Compare Two Dosing Algorithms in Insulin-Naive Patients With Type 2 Diabetes Mellitus
A Phase 3, Open-Label, Parallel-Group Study to Compare Two Dosing Algorithms for Preprandial Human Insulin Inhalation Powder (HIIP) in Insulin-Naive Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 3/7/2018
Clinical Research Facility
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Compare Two Dosing Algorithms in Insulin-Naive Patients With Type 2 Diabetes Mellitus
A Phase 3, Open-Label, Parallel-Group Study to Compare Two Dosing Algorithms for Preprandial Human Insulin Inhalation Powder (HIIP) in Insulin-Naive Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  3/7/2018
Clinical Research Facility
mi
from
Renton, WA
Compare Two Dosing Algorithms in Insulin-Naive Patients With Type 2 Diabetes Mellitus
A Phase 3, Open-Label, Parallel-Group Study to Compare Two Dosing Algorithms for Preprandial Human Insulin Inhalation Powder (HIIP) in Insulin-Naive Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 3/7/2018
Clinical Research Facility
mi
from
Renton, WA
Click here to add this to my saved trials
Compare Two Dosing Algorithms in Insulin-Naive Patients With Type 2 Diabetes Mellitus
A Phase 3, Open-Label, Parallel-Group Study to Compare Two Dosing Algorithms for Preprandial Human Insulin Inhalation Powder (HIIP) in Insulin-Naive Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  3/7/2018
Clinical Research Facility
mi
from
Tacoma, WA
Compare Two Dosing Algorithms in Insulin-Naive Patients With Type 2 Diabetes Mellitus
A Phase 3, Open-Label, Parallel-Group Study to Compare Two Dosing Algorithms for Preprandial Human Insulin Inhalation Powder (HIIP) in Insulin-Naive Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 3/7/2018
Clinical Research Facility
mi
from
Tacoma, WA
Click here to add this to my saved trials
Compare Two Dosing Algorithms in Insulin-Naive Patients With Type 2 Diabetes Mellitus
A Phase 3, Open-Label, Parallel-Group Study to Compare Two Dosing Algorithms for Preprandial Human Insulin Inhalation Powder (HIIP) in Insulin-Naive Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  3/7/2018
mi
from
Buenos Aires,
Compare Two Dosing Algorithms in Insulin-Naive Patients With Type 2 Diabetes Mellitus
A Phase 3, Open-Label, Parallel-Group Study to Compare Two Dosing Algorithms for Preprandial Human Insulin Inhalation Powder (HIIP) in Insulin-Naive Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 3/7/2018
mi
from
Buenos Aires,
Click here to add this to my saved trials
Evaluate the Efficacy and Safety of Insulin Compared to Glargine in Patients With Type 2 Diabetes
A Phase 3, Open-Label, Crossover Study to Evaluate the Efficacy and Safety of Human Insulin Inhalation Powder (HIIP) Compared With Once-Daily Insulin Glargine in Insulin-Naive Patients With Type 2 Diabetes Mellitus on Oral Agents
Status: Enrolling
Updated:  3/7/2018
Clinical Research Facility
mi
from
Greenbrae, CA
Evaluate the Efficacy and Safety of Insulin Compared to Glargine in Patients With Type 2 Diabetes
A Phase 3, Open-Label, Crossover Study to Evaluate the Efficacy and Safety of Human Insulin Inhalation Powder (HIIP) Compared With Once-Daily Insulin Glargine in Insulin-Naive Patients With Type 2 Diabetes Mellitus on Oral Agents
Status: Enrolling
Updated: 3/7/2018
Clinical Research Facility
mi
from
Greenbrae, CA
Click here to add this to my saved trials
Evaluate the Efficacy and Safety of Insulin Compared to Glargine in Patients With Type 2 Diabetes
A Phase 3, Open-Label, Crossover Study to Evaluate the Efficacy and Safety of Human Insulin Inhalation Powder (HIIP) Compared With Once-Daily Insulin Glargine in Insulin-Naive Patients With Type 2 Diabetes Mellitus on Oral Agents
Status: Enrolling
Updated:  3/7/2018
Clinical Research Facility
mi
from
Topeka, KA
Evaluate the Efficacy and Safety of Insulin Compared to Glargine in Patients With Type 2 Diabetes
A Phase 3, Open-Label, Crossover Study to Evaluate the Efficacy and Safety of Human Insulin Inhalation Powder (HIIP) Compared With Once-Daily Insulin Glargine in Insulin-Naive Patients With Type 2 Diabetes Mellitus on Oral Agents
Status: Enrolling
Updated: 3/7/2018
Clinical Research Facility
mi
from
Topeka, KA
Click here to add this to my saved trials
Evaluate the Efficacy and Safety of Insulin Compared to Glargine in Patients With Type 2 Diabetes
A Phase 3, Open-Label, Crossover Study to Evaluate the Efficacy and Safety of Human Insulin Inhalation Powder (HIIP) Compared With Once-Daily Insulin Glargine in Insulin-Naive Patients With Type 2 Diabetes Mellitus on Oral Agents
Status: Enrolling
Updated:  3/7/2018
Clinical Research Facility
mi
from
Toms River, NJ
Evaluate the Efficacy and Safety of Insulin Compared to Glargine in Patients With Type 2 Diabetes
A Phase 3, Open-Label, Crossover Study to Evaluate the Efficacy and Safety of Human Insulin Inhalation Powder (HIIP) Compared With Once-Daily Insulin Glargine in Insulin-Naive Patients With Type 2 Diabetes Mellitus on Oral Agents
Status: Enrolling
Updated: 3/7/2018
Clinical Research Facility
mi
from
Toms River, NJ
Click here to add this to my saved trials
Evaluate the Efficacy and Safety of Insulin Compared to Glargine in Patients With Type 2 Diabetes
A Phase 3, Open-Label, Crossover Study to Evaluate the Efficacy and Safety of Human Insulin Inhalation Powder (HIIP) Compared With Once-Daily Insulin Glargine in Insulin-Naive Patients With Type 2 Diabetes Mellitus on Oral Agents
Status: Enrolling
Updated:  3/7/2018
Clinical Research Facility
mi
from
Albuquerque, NM
Evaluate the Efficacy and Safety of Insulin Compared to Glargine in Patients With Type 2 Diabetes
A Phase 3, Open-Label, Crossover Study to Evaluate the Efficacy and Safety of Human Insulin Inhalation Powder (HIIP) Compared With Once-Daily Insulin Glargine in Insulin-Naive Patients With Type 2 Diabetes Mellitus on Oral Agents
Status: Enrolling
Updated: 3/7/2018
Clinical Research Facility
mi
from
Albuquerque, NM
Click here to add this to my saved trials
Evaluate the Efficacy and Safety of Insulin Compared to Glargine in Patients With Type 2 Diabetes
A Phase 3, Open-Label, Crossover Study to Evaluate the Efficacy and Safety of Human Insulin Inhalation Powder (HIIP) Compared With Once-Daily Insulin Glargine in Insulin-Naive Patients With Type 2 Diabetes Mellitus on Oral Agents
Status: Enrolling
Updated:  3/7/2018
Clinical Research Facility
mi
from
New Braunfels, TX
Evaluate the Efficacy and Safety of Insulin Compared to Glargine in Patients With Type 2 Diabetes
A Phase 3, Open-Label, Crossover Study to Evaluate the Efficacy and Safety of Human Insulin Inhalation Powder (HIIP) Compared With Once-Daily Insulin Glargine in Insulin-Naive Patients With Type 2 Diabetes Mellitus on Oral Agents
Status: Enrolling
Updated: 3/7/2018
Clinical Research Facility
mi
from
New Braunfels, TX
Click here to add this to my saved trials
Evaluate the Efficacy and Safety of Insulin Compared to Glargine in Patients With Type 2 Diabetes
A Phase 3, Open-Label, Crossover Study to Evaluate the Efficacy and Safety of Human Insulin Inhalation Powder (HIIP) Compared With Once-Daily Insulin Glargine in Insulin-Naive Patients With Type 2 Diabetes Mellitus on Oral Agents
Status: Enrolling
Updated:  3/7/2018
Clinical Research Facility
mi
from
San Antonio, TX
Evaluate the Efficacy and Safety of Insulin Compared to Glargine in Patients With Type 2 Diabetes
A Phase 3, Open-Label, Crossover Study to Evaluate the Efficacy and Safety of Human Insulin Inhalation Powder (HIIP) Compared With Once-Daily Insulin Glargine in Insulin-Naive Patients With Type 2 Diabetes Mellitus on Oral Agents
Status: Enrolling
Updated: 3/7/2018
Clinical Research Facility
mi
from
San Antonio, TX
Click here to add this to my saved trials
Evaluate the Efficacy and Safety of Insulin Compared to Glargine in Patients With Type 2 Diabetes
A Phase 3, Open-Label, Crossover Study to Evaluate the Efficacy and Safety of Human Insulin Inhalation Powder (HIIP) Compared With Once-Daily Insulin Glargine in Insulin-Naive Patients With Type 2 Diabetes Mellitus on Oral Agents
Status: Enrolling
Updated:  3/7/2018
Investigational Site Number 4104
mi
from
Porto Alegre,
Evaluate the Efficacy and Safety of Insulin Compared to Glargine in Patients With Type 2 Diabetes
A Phase 3, Open-Label, Crossover Study to Evaluate the Efficacy and Safety of Human Insulin Inhalation Powder (HIIP) Compared With Once-Daily Insulin Glargine in Insulin-Naive Patients With Type 2 Diabetes Mellitus on Oral Agents
Status: Enrolling
Updated: 3/7/2018
Investigational Site Number 4104
mi
from
Porto Alegre,
Click here to add this to my saved trials
Point-of-care Health Literacy and Activation Information to Improve Diabetes Care
Point-of-care Health Literacy and Activation Information to Improve Diabetes Care
Status: Enrolling
Updated:  3/8/2018
Jesse Brown VA Medical Center, Chicago, IL
mi
from
Chicago, IL
Point-of-care Health Literacy and Activation Information to Improve Diabetes Care
Point-of-care Health Literacy and Activation Information to Improve Diabetes Care
Status: Enrolling
Updated: 3/8/2018
Jesse Brown VA Medical Center, Chicago, IL
mi
from
Chicago, IL
Click here to add this to my saved trials
Point-of-care Health Literacy and Activation Information to Improve Diabetes Care
Point-of-care Health Literacy and Activation Information to Improve Diabetes Care
Status: Enrolling
Updated:  3/8/2018
Edward Hines Jr. VA Hospital, Hines, IL
mi
from
Hines, IL
Point-of-care Health Literacy and Activation Information to Improve Diabetes Care
Point-of-care Health Literacy and Activation Information to Improve Diabetes Care
Status: Enrolling
Updated: 3/8/2018
Edward Hines Jr. VA Hospital, Hines, IL
mi
from
Hines, IL
Click here to add this to my saved trials
Point-of-care Health Literacy and Activation Information to Improve Diabetes Care
Point-of-care Health Literacy and Activation Information to Improve Diabetes Care
Status: Enrolling
Updated:  3/8/2018
Michael E. DeBakey VA Medical Center, Houston, TX
mi
from
Houston, TX
Point-of-care Health Literacy and Activation Information to Improve Diabetes Care
Point-of-care Health Literacy and Activation Information to Improve Diabetes Care
Status: Enrolling
Updated: 3/8/2018
Michael E. DeBakey VA Medical Center, Houston, TX
mi
from
Houston, TX
Click here to add this to my saved trials
Brief CBT Interventions Delivered by Nurse Care Managers to Improve Type 2 Diabetes Outcomes: Pilot Study
Brief CBT Interventions Delivered by Nurse Care Managers to Improve Type 2 Diabetes Outcomes: Pilot Study
Status: Enrolling
Updated:  3/9/2018
University of Pittsburgh School of Nursing
mi
from
Pittsburgh, PA
Brief CBT Interventions Delivered by Nurse Care Managers to Improve Type 2 Diabetes Outcomes: Pilot Study
Brief CBT Interventions Delivered by Nurse Care Managers to Improve Type 2 Diabetes Outcomes: Pilot Study
Status: Enrolling
Updated: 3/9/2018
University of Pittsburgh School of Nursing
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
A Study Evaluating the Effect of Albiglutide on Gallbladder Emptying in Healthy Subjects
A Randomized, Double-blind, Single-dose, Placebo Controlled, 2-way Cross-over Study Evaluating Effect of Albiglutide on Cholecystokinin-induced Gallbladder Emptying in Fasting Healthy Subjects
Status: Enrolling
Updated:  3/9/2018
GSK Investigational Site
mi
from
Baltimore, MD
A Study Evaluating the Effect of Albiglutide on Gallbladder Emptying in Healthy Subjects
A Randomized, Double-blind, Single-dose, Placebo Controlled, 2-way Cross-over Study Evaluating Effect of Albiglutide on Cholecystokinin-induced Gallbladder Emptying in Fasting Healthy Subjects
Status: Enrolling
Updated: 3/9/2018
GSK Investigational Site
mi
from
Baltimore, MD
Click here to add this to my saved trials
Safety and Efficacy Study of Mini-Dose Glucagon (G-Pen Mini) in Patients With Type 1 Diabetes
A Randomized, Phase 2a, Blinded, 3-Way Crossover Dose-Ranging Study With G-Pen Mini™ (Glucagon Injection) to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics in Patients With Type 1 Diabetes Mellitus (T1DM)
Status: Enrolling
Updated:  3/10/2018
Baylor College of Medicine, Children's Nutritional Research Center, Texas Children's Hospital
mi
from
Houston, TX
Safety and Efficacy Study of Mini-Dose Glucagon (G-Pen Mini) in Patients With Type 1 Diabetes
A Randomized, Phase 2a, Blinded, 3-Way Crossover Dose-Ranging Study With G-Pen Mini™ (Glucagon Injection) to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics in Patients With Type 1 Diabetes Mellitus (T1DM)
Status: Enrolling
Updated: 3/10/2018
Baylor College of Medicine, Children's Nutritional Research Center, Texas Children's Hospital
mi
from
Houston, TX
Click here to add this to my saved trials
Parental Management of Young Children's Diabetes
Parenting and Control Among Young Children With Type 1 Diabetes
Status: Enrolling
Updated:  3/12/2018
Childrens National Medical Center
mi
from
Washington,
Parental Management of Young Children's Diabetes
Parenting and Control Among Young Children With Type 1 Diabetes
Status: Enrolling
Updated: 3/12/2018
Childrens National Medical Center
mi
from
Washington,
Click here to add this to my saved trials
Parental Management of Young Children's Diabetes
Parenting and Control Among Young Children With Type 1 Diabetes
Status: Enrolling
Updated:  3/12/2018
Virginia Commonwealth University
mi
from
Richmond, VA
Parental Management of Young Children's Diabetes
Parenting and Control Among Young Children With Type 1 Diabetes
Status: Enrolling
Updated: 3/12/2018
Virginia Commonwealth University
mi
from
Richmond, VA
Click here to add this to my saved trials
DermACELL in Subjects With Chronic Wounds of the Lower Extremities
A Multicenter, Randomized, Controlled, Open Label Trial of DermACELL in Subjects With Chronic Wounds of the Lower Extremities
Status: Enrolling
Updated:  3/12/2018
Institute for Advanced Wound Care
mi
from
Montgomery, AL
DermACELL in Subjects With Chronic Wounds of the Lower Extremities
A Multicenter, Randomized, Controlled, Open Label Trial of DermACELL in Subjects With Chronic Wounds of the Lower Extremities
Status: Enrolling
Updated: 3/12/2018
Institute for Advanced Wound Care
mi
from
Montgomery, AL
Click here to add this to my saved trials
DermACELL in Subjects With Chronic Wounds of the Lower Extremities
A Multicenter, Randomized, Controlled, Open Label Trial of DermACELL in Subjects With Chronic Wounds of the Lower Extremities
Status: Enrolling
Updated:  3/12/2018
Southern Arizona VA Health Care System
mi
from
Tucson, AZ
DermACELL in Subjects With Chronic Wounds of the Lower Extremities
A Multicenter, Randomized, Controlled, Open Label Trial of DermACELL in Subjects With Chronic Wounds of the Lower Extremities
Status: Enrolling
Updated: 3/12/2018
Southern Arizona VA Health Care System
mi
from
Tucson, AZ
Click here to add this to my saved trials
DermACELL in Subjects With Chronic Wounds of the Lower Extremities
A Multicenter, Randomized, Controlled, Open Label Trial of DermACELL in Subjects With Chronic Wounds of the Lower Extremities
Status: Enrolling
Updated:  3/12/2018
ILD Research Center
mi
from
Carlsbad, CA
DermACELL in Subjects With Chronic Wounds of the Lower Extremities
A Multicenter, Randomized, Controlled, Open Label Trial of DermACELL in Subjects With Chronic Wounds of the Lower Extremities
Status: Enrolling
Updated: 3/12/2018
ILD Research Center
mi
from
Carlsbad, CA
Click here to add this to my saved trials
DermACELL in Subjects With Chronic Wounds of the Lower Extremities
A Multicenter, Randomized, Controlled, Open Label Trial of DermACELL in Subjects With Chronic Wounds of the Lower Extremities
Status: Enrolling
Updated:  3/12/2018
Center for Clinical Research
mi
from
Castro Valley, CA
DermACELL in Subjects With Chronic Wounds of the Lower Extremities
A Multicenter, Randomized, Controlled, Open Label Trial of DermACELL in Subjects With Chronic Wounds of the Lower Extremities
Status: Enrolling
Updated: 3/12/2018
Center for Clinical Research
mi
from
Castro Valley, CA
Click here to add this to my saved trials
DermACELL in Subjects With Chronic Wounds of the Lower Extremities
A Multicenter, Randomized, Controlled, Open Label Trial of DermACELL in Subjects With Chronic Wounds of the Lower Extremities
Status: Enrolling
Updated:  3/12/2018
Limb Preservation Platform
mi
from
Fresno, CA
DermACELL in Subjects With Chronic Wounds of the Lower Extremities
A Multicenter, Randomized, Controlled, Open Label Trial of DermACELL in Subjects With Chronic Wounds of the Lower Extremities
Status: Enrolling
Updated: 3/12/2018
Limb Preservation Platform
mi
from
Fresno, CA
Click here to add this to my saved trials
DermACELL in Subjects With Chronic Wounds of the Lower Extremities
A Multicenter, Randomized, Controlled, Open Label Trial of DermACELL in Subjects With Chronic Wounds of the Lower Extremities
Status: Enrolling
Updated:  3/12/2018
Limb Preservation Platform
mi
from
Fresno, CA
DermACELL in Subjects With Chronic Wounds of the Lower Extremities
A Multicenter, Randomized, Controlled, Open Label Trial of DermACELL in Subjects With Chronic Wounds of the Lower Extremities
Status: Enrolling
Updated: 3/12/2018
Limb Preservation Platform
mi
from
Fresno, CA
Click here to add this to my saved trials
DermACELL in Subjects With Chronic Wounds of the Lower Extremities
A Multicenter, Randomized, Controlled, Open Label Trial of DermACELL in Subjects With Chronic Wounds of the Lower Extremities
Status: Enrolling
Updated:  3/12/2018
Fairfield County Foot Surgeons
mi
from
Norwalk, CT
DermACELL in Subjects With Chronic Wounds of the Lower Extremities
A Multicenter, Randomized, Controlled, Open Label Trial of DermACELL in Subjects With Chronic Wounds of the Lower Extremities
Status: Enrolling
Updated: 3/12/2018
Fairfield County Foot Surgeons
mi
from
Norwalk, CT
Click here to add this to my saved trials
DermACELL in Subjects With Chronic Wounds of the Lower Extremities
A Multicenter, Randomized, Controlled, Open Label Trial of DermACELL in Subjects With Chronic Wounds of the Lower Extremities
Status: Enrolling
Updated:  3/12/2018
Andrews Research and Education Institute
mi
from
Gulf Breeze, FL
DermACELL in Subjects With Chronic Wounds of the Lower Extremities
A Multicenter, Randomized, Controlled, Open Label Trial of DermACELL in Subjects With Chronic Wounds of the Lower Extremities
Status: Enrolling
Updated: 3/12/2018
Andrews Research and Education Institute
mi
from
Gulf Breeze, FL
Click here to add this to my saved trials
DermACELL in Subjects With Chronic Wounds of the Lower Extremities
A Multicenter, Randomized, Controlled, Open Label Trial of DermACELL in Subjects With Chronic Wounds of the Lower Extremities
Status: Enrolling
Updated:  3/12/2018
Rosalind Franklin University, CLEAR
mi
from
North Chicago, IL
DermACELL in Subjects With Chronic Wounds of the Lower Extremities
A Multicenter, Randomized, Controlled, Open Label Trial of DermACELL in Subjects With Chronic Wounds of the Lower Extremities
Status: Enrolling
Updated: 3/12/2018
Rosalind Franklin University, CLEAR
mi
from
North Chicago, IL
Click here to add this to my saved trials
DermACELL in Subjects With Chronic Wounds of the Lower Extremities
A Multicenter, Randomized, Controlled, Open Label Trial of DermACELL in Subjects With Chronic Wounds of the Lower Extremities
Status: Enrolling
Updated:  3/12/2018
Boston Medical College
mi
from
Boston, MA
DermACELL in Subjects With Chronic Wounds of the Lower Extremities
A Multicenter, Randomized, Controlled, Open Label Trial of DermACELL in Subjects With Chronic Wounds of the Lower Extremities
Status: Enrolling
Updated: 3/12/2018
Boston Medical College
mi
from
Boston, MA
Click here to add this to my saved trials
DermACELL in Subjects With Chronic Wounds of the Lower Extremities
A Multicenter, Randomized, Controlled, Open Label Trial of DermACELL in Subjects With Chronic Wounds of the Lower Extremities
Status: Enrolling
Updated:  3/12/2018
Wound Institute and Reseach Center
mi
from
Dunmore, PA
DermACELL in Subjects With Chronic Wounds of the Lower Extremities
A Multicenter, Randomized, Controlled, Open Label Trial of DermACELL in Subjects With Chronic Wounds of the Lower Extremities
Status: Enrolling
Updated: 3/12/2018
Wound Institute and Reseach Center
mi
from
Dunmore, PA
Click here to add this to my saved trials
DermACELL in Subjects With Chronic Wounds of the Lower Extremities
A Multicenter, Randomized, Controlled, Open Label Trial of DermACELL in Subjects With Chronic Wounds of the Lower Extremities
Status: Enrolling
Updated:  3/12/2018
VA Pittsburgh Healthcare System
mi
from
Pittsburgh, PA
DermACELL in Subjects With Chronic Wounds of the Lower Extremities
A Multicenter, Randomized, Controlled, Open Label Trial of DermACELL in Subjects With Chronic Wounds of the Lower Extremities
Status: Enrolling
Updated: 3/12/2018
VA Pittsburgh Healthcare System
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Increased Gluconeogenesis is One Cause of Cystic Fibrosis Related Diabetes (CFRD)
Increased Gluconeogenesis is One Cause of CFRD
Status: Enrolling
Updated:  3/12/2018
University of Texas Southwestern
mi
from
Dallas, TX
Increased Gluconeogenesis is One Cause of Cystic Fibrosis Related Diabetes (CFRD)
Increased Gluconeogenesis is One Cause of CFRD
Status: Enrolling
Updated: 3/12/2018
University of Texas Southwestern
mi
from
Dallas, TX
Click here to add this to my saved trials
Home Testing of Day and Night Closed Loop With Pump Suspend Feature
An Open-label, Multi-centre, Randomised, Single-period, Parallel Design Study to Assess the Efficacy, Safety, Utility and Psychosocial Effect of 12 Week Day and Night Automated Closed Loop Glucose Control Combined With Pump Suspend Feature Compared to Sensor Augmented Insulin Pump Therapy in Youth and Adults With Type 1 Diabetes With Sub-optimal Glucose Control Under Free Living Conditions
Status: Enrolling
Updated:  3/12/2018
University of Colorado Denver
mi
from
Aurora, CO
Home Testing of Day and Night Closed Loop With Pump Suspend Feature
An Open-label, Multi-centre, Randomised, Single-period, Parallel Design Study to Assess the Efficacy, Safety, Utility and Psychosocial Effect of 12 Week Day and Night Automated Closed Loop Glucose Control Combined With Pump Suspend Feature Compared to Sensor Augmented Insulin Pump Therapy in Youth and Adults With Type 1 Diabetes With Sub-optimal Glucose Control Under Free Living Conditions
Status: Enrolling
Updated: 3/12/2018
University of Colorado Denver
mi
from
Aurora, CO
Click here to add this to my saved trials
Home Testing of Day and Night Closed Loop With Pump Suspend Feature
An Open-label, Multi-centre, Randomised, Single-period, Parallel Design Study to Assess the Efficacy, Safety, Utility and Psychosocial Effect of 12 Week Day and Night Automated Closed Loop Glucose Control Combined With Pump Suspend Feature Compared to Sensor Augmented Insulin Pump Therapy in Youth and Adults With Type 1 Diabetes With Sub-optimal Glucose Control Under Free Living Conditions
Status: Enrolling
Updated:  3/12/2018
International Diabetes Center-Park Nicollet
mi
from
Minneapolis, MN
Home Testing of Day and Night Closed Loop With Pump Suspend Feature
An Open-label, Multi-centre, Randomised, Single-period, Parallel Design Study to Assess the Efficacy, Safety, Utility and Psychosocial Effect of 12 Week Day and Night Automated Closed Loop Glucose Control Combined With Pump Suspend Feature Compared to Sensor Augmented Insulin Pump Therapy in Youth and Adults With Type 1 Diabetes With Sub-optimal Glucose Control Under Free Living Conditions
Status: Enrolling
Updated: 3/12/2018
International Diabetes Center-Park Nicollet
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Home Testing of Day and Night Closed Loop With Pump Suspend Feature
An Open-label, Multi-centre, Randomised, Single-period, Parallel Design Study to Assess the Efficacy, Safety, Utility and Psychosocial Effect of 12 Week Day and Night Automated Closed Loop Glucose Control Combined With Pump Suspend Feature Compared to Sensor Augmented Insulin Pump Therapy in Youth and Adults With Type 1 Diabetes With Sub-optimal Glucose Control Under Free Living Conditions
Status: Enrolling
Updated:  3/12/2018
International Diabetes Centre at Park Nicollet
mi
from
Minneapolis, MN
Home Testing of Day and Night Closed Loop With Pump Suspend Feature
An Open-label, Multi-centre, Randomised, Single-period, Parallel Design Study to Assess the Efficacy, Safety, Utility and Psychosocial Effect of 12 Week Day and Night Automated Closed Loop Glucose Control Combined With Pump Suspend Feature Compared to Sensor Augmented Insulin Pump Therapy in Youth and Adults With Type 1 Diabetes With Sub-optimal Glucose Control Under Free Living Conditions
Status: Enrolling
Updated: 3/12/2018
International Diabetes Centre at Park Nicollet
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Home Testing of Day and Night Closed Loop With Pump Suspend Feature
An Open-label, Multi-centre, Randomised, Single-period, Parallel Design Study to Assess the Efficacy, Safety, Utility and Psychosocial Effect of 12 Week Day and Night Automated Closed Loop Glucose Control Combined With Pump Suspend Feature Compared to Sensor Augmented Insulin Pump Therapy in Youth and Adults With Type 1 Diabetes With Sub-optimal Glucose Control Under Free Living Conditions
Status: Enrolling
Updated:  3/12/2018
University of Cambridge
mi
from
Cambridge,
Home Testing of Day and Night Closed Loop With Pump Suspend Feature
An Open-label, Multi-centre, Randomised, Single-period, Parallel Design Study to Assess the Efficacy, Safety, Utility and Psychosocial Effect of 12 Week Day and Night Automated Closed Loop Glucose Control Combined With Pump Suspend Feature Compared to Sensor Augmented Insulin Pump Therapy in Youth and Adults With Type 1 Diabetes With Sub-optimal Glucose Control Under Free Living Conditions
Status: Enrolling
Updated: 3/12/2018
University of Cambridge
mi
from
Cambridge,
Click here to add this to my saved trials
Use of Exenatide and Pramlintide to Decrease Post-prandial Hyperglycemia
Exenatide (Byetta) Vs Pramlintide (Symlin): Role in Post-prandial Hyperglycemia
Status: Enrolling
Updated:  3/13/2018
Albert Einstein College of Medicine West Campus Clinical Research Center
mi
from
Bronx, NY
Use of Exenatide and Pramlintide to Decrease Post-prandial Hyperglycemia
Exenatide (Byetta) Vs Pramlintide (Symlin): Role in Post-prandial Hyperglycemia
Status: Enrolling
Updated: 3/13/2018
Albert Einstein College of Medicine West Campus Clinical Research Center
mi
from
Bronx, NY
Click here to add this to my saved trials
A Study to Evaluate the Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) for TAK-906 in Participants With Diabetes Mellitus and Gastroparesis (DG) or With Idiopathic Gastroparesis (IG)
A 2-Part, Randomized, Double Blind and Open-Label, Placebo and Active-Comparator Controlled Trial to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics for TAK-906 in Subjects With Diabetes Mellitus and Gastroparesis or With Idiopathic Gastroparesis
Status: Enrolling
Updated:  3/13/2018
9171 West Thunderbird Road
mi
from
Peoria, AZ
A Study to Evaluate the Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) for TAK-906 in Participants With Diabetes Mellitus and Gastroparesis (DG) or With Idiopathic Gastroparesis (IG)
A 2-Part, Randomized, Double Blind and Open-Label, Placebo and Active-Comparator Controlled Trial to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics for TAK-906 in Subjects With Diabetes Mellitus and Gastroparesis or With Idiopathic Gastroparesis
Status: Enrolling
Updated: 3/13/2018
9171 West Thunderbird Road
mi
from
Peoria, AZ
Click here to add this to my saved trials
A Study to Evaluate the Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) for TAK-906 in Participants With Diabetes Mellitus and Gastroparesis (DG) or With Idiopathic Gastroparesis (IG)
A 2-Part, Randomized, Double Blind and Open-Label, Placebo and Active-Comparator Controlled Trial to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics for TAK-906 in Subjects With Diabetes Mellitus and Gastroparesis or With Idiopathic Gastroparesis
Status: Enrolling
Updated:  3/13/2018
850 North Kolb Road
mi
from
Tucson, AZ
A Study to Evaluate the Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) for TAK-906 in Participants With Diabetes Mellitus and Gastroparesis (DG) or With Idiopathic Gastroparesis (IG)
A 2-Part, Randomized, Double Blind and Open-Label, Placebo and Active-Comparator Controlled Trial to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics for TAK-906 in Subjects With Diabetes Mellitus and Gastroparesis or With Idiopathic Gastroparesis
Status: Enrolling
Updated: 3/13/2018
850 North Kolb Road
mi
from
Tucson, AZ
Click here to add this to my saved trials
A Study to Evaluate the Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) for TAK-906 in Participants With Diabetes Mellitus and Gastroparesis (DG) or With Idiopathic Gastroparesis (IG)
A 2-Part, Randomized, Double Blind and Open-Label, Placebo and Active-Comparator Controlled Trial to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics for TAK-906 in Subjects With Diabetes Mellitus and Gastroparesis or With Idiopathic Gastroparesis
Status: Enrolling
Updated:  3/13/2018
11219 Financial Centre Parkway
mi
from
Little Rock, AR
A Study to Evaluate the Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) for TAK-906 in Participants With Diabetes Mellitus and Gastroparesis (DG) or With Idiopathic Gastroparesis (IG)
A 2-Part, Randomized, Double Blind and Open-Label, Placebo and Active-Comparator Controlled Trial to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics for TAK-906 in Subjects With Diabetes Mellitus and Gastroparesis or With Idiopathic Gastroparesis
Status: Enrolling
Updated: 3/13/2018
11219 Financial Centre Parkway
mi
from
Little Rock, AR
Click here to add this to my saved trials
A Study to Evaluate the Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) for TAK-906 in Participants With Diabetes Mellitus and Gastroparesis (DG) or With Idiopathic Gastroparesis (IG)
A 2-Part, Randomized, Double Blind and Open-Label, Placebo and Active-Comparator Controlled Trial to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics for TAK-906 in Subjects With Diabetes Mellitus and Gastroparesis or With Idiopathic Gastroparesis
Status: Enrolling
Updated:  3/13/2018
13055 Southwest 42nd Street
mi
from
Miami, FL
A Study to Evaluate the Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) for TAK-906 in Participants With Diabetes Mellitus and Gastroparesis (DG) or With Idiopathic Gastroparesis (IG)
A 2-Part, Randomized, Double Blind and Open-Label, Placebo and Active-Comparator Controlled Trial to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics for TAK-906 in Subjects With Diabetes Mellitus and Gastroparesis or With Idiopathic Gastroparesis
Status: Enrolling
Updated: 3/13/2018
13055 Southwest 42nd Street
mi
from
Miami, FL
Click here to add this to my saved trials
A Study to Evaluate the Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) for TAK-906 in Participants With Diabetes Mellitus and Gastroparesis (DG) or With Idiopathic Gastroparesis (IG)
A 2-Part, Randomized, Double Blind and Open-Label, Placebo and Active-Comparator Controlled Trial to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics for TAK-906 in Subjects With Diabetes Mellitus and Gastroparesis or With Idiopathic Gastroparesis
Status: Enrolling
Updated:  3/13/2018
8200 Southwest 117th Avenue
mi
from
Miami, FL
A Study to Evaluate the Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) for TAK-906 in Participants With Diabetes Mellitus and Gastroparesis (DG) or With Idiopathic Gastroparesis (IG)
A 2-Part, Randomized, Double Blind and Open-Label, Placebo and Active-Comparator Controlled Trial to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics for TAK-906 in Subjects With Diabetes Mellitus and Gastroparesis or With Idiopathic Gastroparesis
Status: Enrolling
Updated: 3/13/2018
8200 Southwest 117th Avenue
mi
from
Miami, FL
Click here to add this to my saved trials
A Study to Evaluate the Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) for TAK-906 in Participants With Diabetes Mellitus and Gastroparesis (DG) or With Idiopathic Gastroparesis (IG)
A 2-Part, Randomized, Double Blind and Open-Label, Placebo and Active-Comparator Controlled Trial to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics for TAK-906 in Subjects With Diabetes Mellitus and Gastroparesis or With Idiopathic Gastroparesis
Status: Enrolling
Updated:  3/13/2018
125 Clairemont Avenue
mi
from
Decatur, GA
A Study to Evaluate the Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) for TAK-906 in Participants With Diabetes Mellitus and Gastroparesis (DG) or With Idiopathic Gastroparesis (IG)
A 2-Part, Randomized, Double Blind and Open-Label, Placebo and Active-Comparator Controlled Trial to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics for TAK-906 in Subjects With Diabetes Mellitus and Gastroparesis or With Idiopathic Gastroparesis
Status: Enrolling
Updated: 3/13/2018
125 Clairemont Avenue
mi
from
Decatur, GA
Click here to add this to my saved trials
A Study to Evaluate the Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) for TAK-906 in Participants With Diabetes Mellitus and Gastroparesis (DG) or With Idiopathic Gastroparesis (IG)
A 2-Part, Randomized, Double Blind and Open-Label, Placebo and Active-Comparator Controlled Trial to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics for TAK-906 in Subjects With Diabetes Mellitus and Gastroparesis or With Idiopathic Gastroparesis
Status: Enrolling
Updated:  3/13/2018
616 South Washington Street
mi
from
Bastrop, LA
A Study to Evaluate the Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) for TAK-906 in Participants With Diabetes Mellitus and Gastroparesis (DG) or With Idiopathic Gastroparesis (IG)
A 2-Part, Randomized, Double Blind and Open-Label, Placebo and Active-Comparator Controlled Trial to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics for TAK-906 in Subjects With Diabetes Mellitus and Gastroparesis or With Idiopathic Gastroparesis
Status: Enrolling
Updated: 3/13/2018
616 South Washington Street
mi
from
Bastrop, LA
Click here to add this to my saved trials
A Study to Evaluate the Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) for TAK-906 in Participants With Diabetes Mellitus and Gastroparesis (DG) or With Idiopathic Gastroparesis (IG)
A 2-Part, Randomized, Double Blind and Open-Label, Placebo and Active-Comparator Controlled Trial to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics for TAK-906 in Subjects With Diabetes Mellitus and Gastroparesis or With Idiopathic Gastroparesis
Status: Enrolling
Updated:  3/13/2018
6035 Shallowford Road
mi
from
Chattanooga, TN
A Study to Evaluate the Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) for TAK-906 in Participants With Diabetes Mellitus and Gastroparesis (DG) or With Idiopathic Gastroparesis (IG)
A 2-Part, Randomized, Double Blind and Open-Label, Placebo and Active-Comparator Controlled Trial to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics for TAK-906 in Subjects With Diabetes Mellitus and Gastroparesis or With Idiopathic Gastroparesis
Status: Enrolling
Updated: 3/13/2018
6035 Shallowford Road
mi
from
Chattanooga, TN
Click here to add this to my saved trials
A Study to Evaluate the Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) for TAK-906 in Participants With Diabetes Mellitus and Gastroparesis (DG) or With Idiopathic Gastroparesis (IG)
A 2-Part, Randomized, Double Blind and Open-Label, Placebo and Active-Comparator Controlled Trial to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics for TAK-906 in Subjects With Diabetes Mellitus and Gastroparesis or With Idiopathic Gastroparesis
Status: Enrolling
Updated:  3/13/2018
26 Stonecreek Circle
mi
from
Jackson, TN
A Study to Evaluate the Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) for TAK-906 in Participants With Diabetes Mellitus and Gastroparesis (DG) or With Idiopathic Gastroparesis (IG)
A 2-Part, Randomized, Double Blind and Open-Label, Placebo and Active-Comparator Controlled Trial to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics for TAK-906 in Subjects With Diabetes Mellitus and Gastroparesis or With Idiopathic Gastroparesis
Status: Enrolling
Updated: 3/13/2018
26 Stonecreek Circle
mi
from
Jackson, TN
Click here to add this to my saved trials
Use of Levemir® Improves Metabolic and Clinical Status in Cystic Fibrosis-related Diabetes (CFRD)
Use of Levemir® Improves Metabolic and Clinical Status in CFRD
Status: Enrolling
Updated:  3/14/2018
Nationwide Children's Hospital
mi
from
Columbus, OH
Use of Levemir® Improves Metabolic and Clinical Status in Cystic Fibrosis-related Diabetes (CFRD)
Use of Levemir® Improves Metabolic and Clinical Status in CFRD
Status: Enrolling
Updated: 3/14/2018
Nationwide Children's Hospital
mi
from
Columbus, OH
Click here to add this to my saved trials
Efficacy Study of Interactive Web Application for Problem Solving in Diabetes Management
Randomized Clinical Trial of Health Information Technology for Problem Solving in Diabetes Management
Status: Enrolling
Updated:  3/14/2018
Clinical Directors Network
mi
from
New York, NY
Efficacy Study of Interactive Web Application for Problem Solving in Diabetes Management
Randomized Clinical Trial of Health Information Technology for Problem Solving in Diabetes Management
Status: Enrolling
Updated: 3/14/2018
Clinical Directors Network
mi
from
New York, NY
Click here to add this to my saved trials